DAVOS, Switzerland (Reuters) - Novartis Chief Executive Joe Jimenez played down talk that it was looking to sell its one-third voting stake in crosstown rival Roche, and certainly not at its current market price. There has been widespread speculation that the Novartis could be heading for a change of strategic direction - including a possible sale of the Roche stake - following the appointment of a new chairman on Wednesday. "It's a strategic purchase," Jimenez said of the holding during an interview at the World Economic Forum in Davos. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment